Nuns should take contraceptive pill to cut cancer risk

By Admin
While writing in the Lancet medical journal two health experts have claimed nuns should take the contraceptive pill to reduce their risk of developing...

While writing in the Lancet medical journal two health experts have claimed nuns should take the contraceptive pill to reduce their risk of developing cancer.

It is commonly believed that women who do not go through pregnancy or breastfeed children are more at risk of developing breast, womb and ovarian cancer as they have more periods in their lifetime.

Studies of nuns have also found that cancer-related mortality rates are higher among nuns than other women.  

To read the latest edition of Healthcare Global, click here

According to the two Australian researchers, overall mortality rates are 12 percent lower in pill-takers and the risk of breast, ovarian and womb cancer is cut by approximately 50-60 percent if women take the pill.

However, nuns have been banned from taking any kind of contraception apart from abstinence.

Professor Roger Short, from the University of Melbourne, and Dr Kara Britt, from Melbourne’s Monash University, said in their Lancet opinion article that nuns “pay a terrible price for their chastity because they have a greatly increased risk of breast, ovarian, and uterine cancers.

They also said: “The Catholic church condemns all forms of contraception except abstinence, as outlined by Pope Paul VI in Humanae Vitae in 1968.

“If the Catholic Church could make the contraceptive pill freely available to all its nuns, it would reduce the risk of those accursed pests, cancer of the ovary and uterus, and give nuns’ plight the recognition it deserves.”

Our magazine is now available on the iPad. Click here to download it.

Share

Featured Articles

Global Health Funding 'Facing Post-Pandemic Challenges'

IHME report highlights shifting priorities and economic pressures affecting global health financing, despite increase in funding since pre-COVID levels

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Procurement & Supply Chain

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare